Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy

Annals of Surgical Oncology

Volumn 19, Issue 10, 2012, Pages 3131-3138

  Shah Khan, Miraj G ^a   Geiger, Xochiquetzal J ^b   Reynolds, Carol ^a   Jakub, James W ^a   DePeri, Elizabeth R ^b   Glazebrook, Katrina N ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL LOBULAR HYPERPLASIA; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CORE NEEDLE BIOPSY; EXCISION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; INTRADUCTAL CARCINOMA; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; NEEDLE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TIME FACTORS;

EID: 84868214596     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2534-9     Document Type: Article

References (44)

1. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737-69. (Pubitemid 8406608)
2. Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23:5534-41.
3. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia. Long-term risk of breast cancer and relation to other factors. Cancer 1996;78:1024-34. (Pubitemid 26284867)
4. Simpson PT, Gale T, Fulford LG, et al. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 2003;5:258-62. (Pubitemid 37080856)
5. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-9. (Pubitemid 36092016)
6. Dershaw DD. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision? Breast J. 2003;9:1-3. (Pubitemid 36176455)
7. Cited with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Breast Cancer (V.1.2012) c 2012. National Comprehensive Cancer Network, Inc. All rights reserved. Available at: NCCN.org. Accessed 3/1/ 2012. The NCCN Guidelines™ herein may not be reproduced without the express written permission of the NCCN. To view the most recent and complete version of the NCCN Guidelines, go on-line to NCCN.org.
8. Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002;75:259-68. (Pubitemid 35026119)
9. Oppong BA, King TA. Recommendations for women with lobular carcinoma in situ (LCIS). Oncology (Williston Park). 2011;25:1051-56, 1058.
10. VisscherDW, Hartmann LC. Lobular neoplasia: howto manage with partial understanding. Oncology (Williston Park). 2011;25:1066-8.
11. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173:291-9. (Pubitemid 29347344)
12. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001;218:503-9. (Pubitemid 32121066)
13. Hussain M, Cunnick GH. Management of lobular carcinoma insitu and atypical lobular hyperplasia of the breast-A review. Eur J Surg Oncol. 2011;37:279-89.
14. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000;216:831-7. (Pubitemid 30660861)
15. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436:421-30. (Pubitemid 30312157)
16. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176:1255-9. (Pubitemid 32323271)
17. Londero V, Zuiani C, Linda A, et al. Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast. 2008;17:623-30.
18. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med. 2005;143:446-57. (Pubitemid 41338942)
19. Nagi CS, O'Donnell JE, Tismenetsky M, et al. Lobular neoplasia on core needle biopsy does not require excision. Cancer. 2008; 112:2152-8. (Pubitemid 351628623)
20. Hwang H, Barke LD, Mendelson EB, Susnik B. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 2008; 21:1208-16.
21. Cohen M.A. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology. 2004;231: 617-21. (Pubitemid 38668074)
22. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005; 29:534-43. (Pubitemid 40411188)
23. Brem RF, Lechner MC, Jackman RJ, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 2008;190:637-41. (Pubitemid 351304506)
24. Renshaw AA, Derhagopian RP, Martinez P, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol. 2006;126:310-3. (Pubitemid 44162579)
25. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-51. (Pubitemid 15192861)
26. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941-4.
27. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229-37. (Pubitemid 41058322)
28. Page DL, Kidd TE Jr, Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232-9.
29. Fisher ER, Land SR, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100:238-44. (Pubitemid 38063630)
30. Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer. 2006;42:2205-11. (Pubitemid 44316899)
31. King TA, Sakr RA, Muhsen S, et al. Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol. 2012;19: 1115-21.
32. Hwang ES, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004;100:2562-72. (Pubitemid 38715760)
33. Mastracci TL, Shadeo A, Colby SM, et al. Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferation in the breast. Genes Chromosomes Cancer. 2006;45:1007-17. (Pubitemid 44435535)
34. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997;183:404-11. (Pubitemid 27509246)
35. Esserman LE, Lamea L, Tanev S, Poppiti R. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J. 2007;13:55-61. (Pubitemid 46046494)
36. Rendi MH, Dintzis SM, Lehman CD, et al. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 2012;19:914-21.
37. Middleton LP, Grant S, Stephens T et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003;16:120-9. (Pubitemid 36245743)
38. Mahoney MC, Robinson-Smith ™, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-A ssisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 2006;187:949-54. (Pubitemid 44453948)
39. Menon S, Porter GJ, Evans AJ, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch. 2008;452:473-9.
40. Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004;231:813-9. (Pubitemid 38668103)
41. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002;126:697-701. (Pubitemid 34602571)
42. Crisi GM, Mandavilli S, Cronin E, Ricci A Jr. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol. 2003;27:325-33. (Pubitemid 36245797)
43. Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy? A report of 38 cases and review of the literature. Arch Pathol Lab Med. 2008;132:979-83. (Pubitemid 351918705)
44. Yeh IT, Dimitrov D, Otto P, et al. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med. 2003;127:49-54. (Pubitemid 36236579)